PEG IFN-alpha-2b effective against HBeAg+ hepatitis BHepatitis-B, treatmentLamivudine, therapeutic usePeginterferon-alfa-2b, therapeutic use
Efficacy of peginterferon alpha-2b in chronic hepatitis delta: relevance of quantitative RT-PCR for follow-up. Hepatology 2006;44:728--35.Castelnau C, Le Gal F, Ripault MP, Gordien E, Martinot-Peignoux M, Boyer N, et al. Efficacy of peginterferon alpha-2b in chronic...
PEG IFN-alpha-2b plus ribavirin worth its cost in chronic hepatitis CCost-utilityHepatitis-C, treatmentInterferon-alpha-2b, therapeutic usePEG-interferon-alpha-2b, therapeutic useRibavirin, therapeutic useInpharma Weekly -doi:10.2165/00128413-200313790-00013None...
Hepatitis-C, treatmentPeginterferon-alfa-2b, therapeutic useRibavirin, therapeutic use
Insulin resistance (IR) - an important prognostic factor reducing the effectiveness of the antiviral therapy in patients with chronic hepatitis C. Using of metformin as a drug which normalize the level of insulin resistance in CHC patients, treated with Peg- IFNalpha-2b+ribavirin increases its ...
High incidence of depression and sleep disturbances associated with PegIFN-alpha-2b/ribivirin therapy for hepatitis C in routine clinical practiceThe American Journal of Gastroenterology is published by Nature Publishing Group (NPG) on behalf of the American College of Gastroenterology (ACG). Ranked ...
An abstract of the article "High Incidence of Depression and Sleep Disturbances Associated with PegIFN-Alpha-2b/Ribivirin Therapy for Hepatitis C in Routine Clinical Practice," by David Finkelman is presented.doi:10.1111/j.1572-0241.2003.07986.xFinkelman...
PGI8 COST-EFFECTIVENESS OF PEG-IFN ALPHA 2A OR 2B PLUS RIBAVIRIN IN THE TREATMENT OF CHRONIC HEPATITIS C IN MEXICOdoi:10.1016/s1098-3015(10)73355-6G Salinas EscuderoJ IdrovoR RivasJ Ramirez RodriguezIA Rico AlbaL ZapataElsevierValue in Health...
Peginterferon-alfa-2b, therapeutic useRegulatory-processRibavirin, therapeutic useNA;Inpharma weekly
Baseline platelet count predicts sustained viral response (SVR) in the treatment of chronic hepatitis C with Peg-IFN alpha-2b and rib-avirin: Results from the German Peg-IFN alpha-2b observational studyMauss, SZehnter, EManns, M PTeuber, G...